Current safety of the blood supply in the United States

International Journal of Hematology

Volumn 80, Issue 4, 2004, Pages 301-305

  Dodd, Roger Y ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

Blood transfusion; Emerging infections; Hepatitis B; Hepatitis C; HIV

Indexed keywords

BABESIA MICROTI; BABESIOSIS; BLOOD DONOR; BLOOD TRANSFUSION; CHAGAS DISEASE; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS; LABORATORY TEST; MALARIA; MICROBIAL CONTAMINATION; NUCLEIC ACID AMPLIFICATION; REVIEW; SAFETY; SYPHILIS; THROMBOCYTE TRANSFUSION; TRYPANOSOMA; UNITED STATES; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

BLOOD BANKS; BLOOD-BORNE PATHOGENS; HUMANS; INFECTION; SAFETY; UNITED STATES;

EID: 9444266565     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.04123     Document Type: Review

References (29)

1. Dodd RY, Notari EP, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion. 2002;42:975-979.
2. Stramer SL, Glynn SA, Kleinman SH, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med. 2004;351:760-768.
3. Goodman JL. The safety and availability of blood and tissues: progress and challenges. N Engl J Med. 2004;351:819-822.
4. Dodd RY, Leiby DA. Emerging infectious threats to the blood supply. Annu Rev Med. 2004;55:191-207.
5. Williams AE, Thomson RA, Schreiber OB, et al. Estimates of infectious disease risk factors in US blood donors. JAMA. 1997;277: 967-972.
6. Zou S, Dodd RY, Stramer SL, Strong DM. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med. 2004;351:751-759.
7. Delwart EL, Kalmin ND, Jones TS, et al. First report of human immunodeficiency virus transmission via an RNA-screened blood donation. Vox Sang. 2004;86:171-177.
8. Phelps R, Robbins K, Liberti T, et al. Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor. Transfusion. 2004;44:929-933.
9. Schüttler CG, Caspari G, Jursch CA, et al. Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA. Lancet. 2000;355:41-42.
10. Busch MP. Closing the windows on viral transmission by blood transfusion. In: Stramer SL, ed. Blood Safety in the New Millenium. Bethesda, MD: American Association of Blood Banks; 2001:33-54.
11. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA. 1998;280:42-48.
12. Biggerstaff BJ, Petersen LR. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion. 2002;42:1019-1026.
13. Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med. 2003;349:1236-1245.
14. Dodd RY. Emerging infections, transfusion safety, and epidemiology. N Engl J Med. 2003;349:1205-1206.
15. Biggerstaff BJ, Petersen LR. Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002. Transfusion. 2003;43:1007-1017.
16. Orton S. Syphilis and blood donors: what we know, what we do not know, and what we need to know. Transfus Med Rev. 2001;15: 282-291.
17. Orton SL, Liu H, Dodd RY, et al. Prevalence of circulating Treponema pallidum DNA and RNA in blood donors with confirmed-positive syphilis tests. Transfusion. 2002;42:94-99.
18. Mungai M, Tegtmeier G, Chamberland M, et al. Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med. 2001;344:1973-1978.
19. Leiby DA, Lenes BA,Tibbals MA, et al. Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N Engl J Med. 1999;341:1237-1239.
20. Leiby DA, Read EJ, Lenes BA, et al. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors. J Infect Dis. 1997;176:1047-1052.
21. Leiby DA, Rentas FJ, Nelson KE, et al. Evidence of Trypanosoma cruzi infection (Chagas' disease) among patients undergoing cardiac surgery. Circulation. 2000;102:2978-2982.
22. Matsui T, Inoue R, Kajimoto K, et al. First documentation of transfusion-associated babesiosis in Japan [in Japanese]. Rinsho Ketsueki. 2000;41:628-634.
23. Prusiner SB. Prion diseases and the BSE crisis. Science. 1997;278: 245-251.
24. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci. 2001;24:519-550.
25. Collinge J. Variant Creutzfeldt-Jakob disease. Lancet. 1999;354: 317-323.
26. Peden AH, Head MW, Ritchie DL, et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet. 2004;364:527-529.
27. Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet. 2004;363:417-421.
28. Kuehnert MJ, Roth VR, Haley NR, et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion. 2001;41:1493-1499.
29. Ness P, Braine H, King K, et al. Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion. 2001;41: 857-861.